BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25472776)

  • 1. Antitumor evaluation and molecular docking study of substituted 2-benzylidenebutane-1,3-dione, 2-hydrazonobutane-1,3-dione and trifluoromethyl-1H-pyrazole analogues.
    Al-Suwaidan IA; Abdel-Aziz NI; El-Azab AS; El-Sayed MA; Alanazi AM; El-Ashmawy MB; Abdel-Aziz AA
    J Enzyme Inhib Med Chem; 2015; 30(4):679-87. PubMed ID: 25472776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents.
    Insuasty B; Tigreros A; Orozco F; Quiroga J; Abonía R; Nogueras M; Sanchez A; Cobo J
    Bioorg Med Chem; 2010 Jul; 18(14):4965-74. PubMed ID: 20594863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, antitumor activity and molecular docking study of some novel 3-benzyl-4(3H)quinazolinone analogues.
    Al-Suwaidan IA; Abdel-Aziz AA; Shawer TZ; Ayyad RR; Alanazi AM; El-Morsy AM; Mohamed MA; Abdel-Aziz NI; El-Sayed MA; El-Azab AS
    J Enzyme Inhib Med Chem; 2016; 31(1):78-89. PubMed ID: 25815668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of C3-pyrazole/chalcone-linked beta-carboline hybrids: antitopoisomerase I, DNA-interactive, and apoptosis-inducing anticancer agents.
    Kamal A; Srinivasulu V; Nayak VL; Sathish M; Shankaraiah N; Bagul C; Reddy NV; Rangaraj N; Nagesh N
    ChemMedChem; 2014 Sep; 9(9):2084-98. PubMed ID: 24470122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro antitumor evaluation of some indeno[1,2-c]pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems.
    Rostom SA
    Bioorg Med Chem; 2006 Oct; 14(19):6475-85. PubMed ID: 16806944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and anticervical cancer activity of new benzofuran-pyrazol-hydrazono- thiazolidin-4-one hybrids as potential EGFR inhibitors and apoptosis inducing agents.
    Abbas HS; Abd El-Karim SS
    Bioorg Chem; 2019 Aug; 89():103035. PubMed ID: 31200286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polysubstituted pyrazoles, part 6. Synthesis of some 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazol-3-carbonyl derivatives linked to nitrogenous heterocyclic ring systems as potential antitumor agents.
    Rostom SA
    Bioorg Med Chem; 2010 Apr; 18(7):2767-76. PubMed ID: 20207545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity.
    Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J
    Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysubstituted pyrazoles, part 5. Synthesis of new 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazole-3-carboxylic acid hydrazide analogs and some derived ring systems. A novel class of potential antitumor and anti-HCV agents.
    Rostom SA; Shalaby MA; El-Demellawy MA
    Eur J Med Chem; 2003; 38(11-12):959-74. PubMed ID: 14642328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of 2-mercapto-3-phenethylquinazoline bearing anilide fragments as potential antitumor agents: molecular docking study.
    Al-Suwaidan IA; Alanazi AM; Abdel-Aziz AA; Mohamed MA; El-Azab AS
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3935-41. PubMed ID: 23683592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, Characterization, and Biological Study of 3-Trifluoromethylpyrazole Tethered Chalcone-Pyrrole and Pyrazoline-Pyrrole Derivatives.
    Kisan Rasal N; Bhaskar Sonawane R; Vijay Jagtap S
    Chem Biodivers; 2021 Oct; 18(10):e2100504. PubMed ID: 34409724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anticancer activity of isatin-based pyrazolines and thiazolidines conjugates.
    Havrylyuk D; Kovach N; Zimenkovsky B; Vasylenko O; Lesyk R
    Arch Pharm (Weinheim); 2011 Aug; 344(8):514-22. PubMed ID: 21681810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents.
    Huang XF; Lu X; Zhang Y; Song GQ; He QL; Li QS; Yang XH; Wei Y; Zhu HL
    Bioorg Med Chem; 2012 Aug; 20(16):4895-900. PubMed ID: 22819191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification, Biological Evaluation and SAR Studies of Novel 1H-Pyrazol Derivatives Containing N,N'-Disubstituted Urea Moiety as Potential Anti-melanoma Agents.
    Ruan BF; Lin MX; Shao Q; Wang TH; Zhang Q; Dong YL; Bu CN; Xu HJ; Zhou BG; Li QS
    Chem Biodivers; 2018 Jun; 15(6):e1700504. PubMed ID: 29687639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Biological Evaluation of Pyrazoline and Pyrrolidine-2,5-dione Hybrids as Potential Antitumor Agents.
    Tilekar K; Upadhyay N; Meyer-Almes FJ; Loiodice F; Anisimova NY; Spirina TS; Sokolova DV; Smirnova GB; Choe JY; Pokrovsky VS; Lavecchia A; S Ramaa C
    ChemMedChem; 2020 Oct; 15(19):1813-1825. PubMed ID: 32715626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
    Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, in vitro antitumour activity, and molecular docking study of novel 2-substituted mercapto-3-(3,4,5-trimethoxybenzyl)-4(3H)-quinazolinone analogues.
    El-Azab AS; Abdel-Aziz AA; Ghabbour HA; Al-Gendy MA
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1229-1239. PubMed ID: 28948843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, crystal structure and biological evaluation of novel 2-(5-(hydroxymethyl)-3-phenyl-1H-pyrazol-1-yl)-1-phenylethanol derivatives.
    Zheng LW; Zhu J; Zhao BX; Huang YH; Ding J; Miao JY
    Eur J Med Chem; 2010 Dec; 45(12):5792-9. PubMed ID: 20947221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of novel 5-phenyl-1H-pyrazole derivatives as potential BRAF(V600E) inhibitors.
    Wang SF; Zhu YL; Zhu PT; Makawana JA; Zhang YL; Zhao MY; Lv PC; Zhu HL
    Bioorg Med Chem; 2014 Nov; 22(21):6201-8. PubMed ID: 25267006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Cytotoxicity Evaluation, Molecular Docking and Utility of Novel Chalcones as Precursors for Heterocycles Incorporating Pyrazole Moiety.
    Gomha SM; Abdallah MA; Abbas IM; Kazem MSH
    Med Chem; 2018; 14(4):344-355. PubMed ID: 29065841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.